Core Laboratories Shareholders Approve Key Governance Items

The latest announcement is out from Core Laboratories ( (CLB) ).

On May 21, 2025, Core Laboratories Inc. held its Annual Meeting of Shareholders in Houston, Texas, where all proposed items were approved. Shareholders elected one new and re-elected two Class II Directors, ratified KPMG as the independent public accountant for 2025, and approved the executive compensation policies, reflecting strong shareholder support for the company’s governance and financial strategies.

The most recent analyst rating on (CLB) stock is a Sell with a $13.00 price target. To see the full list of analyst forecasts on Core Laboratories stock, see the CLB Stock Forecast page.

Spark’s Take on CLB Stock

According to Spark, TipRanks’ AI Analyst, CLB is a Neutral.

Core Laboratories’ stock score reflects its stable financial performance and effective cash flow management. However, technical indicators suggest bearish trends, and valuation appears moderate with a low dividend yield. Recent earnings call data points to both strategic improvements and significant external challenges. The stock’s potential recovery is contingent on overcoming geopolitical and market hurdles.

To see Spark’s full report on CLB stock, click here.

More about Core Laboratories

Core Laboratories Inc. operates in the oil and gas industry, providing reservoir description, production enhancement, and reservoir management services. The company focuses on optimizing petroleum reservoir performance through its innovative technologies and services.

Average Trading Volume: 514,421

Technical Sentiment Signal: Sell

Current Market Cap: $508.7M

For an in-depth examination of CLB stock, go to TipRanks’ Stock Analysis page.